Edition:
United States

ZIOPHARM Oncology Inc (ZIOP.OQ)

ZIOP.OQ on NASDAQ Stock Exchange Capital Market

4.36USD
12 Jan 2018
Change (% chg)

-- (--)
Prev Close
$4.36
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
337,125
52-wk High
$7.88
52-wk Low
$3.77

Chart for

About

ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which is seeking to develop, acquire and commercialize, on its own or with partners, a portfolio of cancer therapies that address unmet medical needs. The Company is focused on developing products in immuno-oncology that employ gene expression, control and cell technologies... (more)

Overall

Beta: 1.52
Market Cap(Mil.): $618.96
Shares Outstanding(Mil.): 141.96
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 217.08 16.42
EPS (TTM): -- -- --
ROI: -- -11.57 34.33
ROE: -- -34.40 17.15

BRIEF-Ziopharm Oncology To Initiate Pivotal Trial Of Cancer Treatment in Second Half of 2018

* ZIOPHARM ONCOLOGY PROVIDES UPDATE ON STANDOUT TECHNOLOGIES DURING THE 36TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Jan 09 2018

BRIEF-Ziopharm Oncology reports third quarter financial results

* Ziopharm Oncology reports third quarter 2017 financial results and provides update on recent activities

Nov 06 2017

BRIEF-Ziopharm Oncology reports Q2 loss per share $0.13

* Ziopharm Oncology reports second quarter 2017 financial results and provides update on recent activities

Jul 31 2017

Earnings vs. Estimates